Taro

The Best- And Worst-Performing Biotech Stocks In February

The Best- And Worst-Performing Biotech Stocks In February

Forbes

India's Sun Pharma ends deal to take over Israeli unit Taro

India's Sun Pharma ends deal to take over Israeli unit Taro

Reuters

Taro Provides Third Quarter and Fiscal Year to Date Results

Taro Provides Third Quarter and Fiscal Year to Date Results

Yahoo

Why Taro Shareholders Should Reject Sun Pharmaceuticals Offer

Why Taro Shareholders Should Reject Sun Pharmaceuticals Offer

Seeking Alpha

Sun Pharma to take Taro private for $571m

Sun Pharma to take Taro private for $571m

Globes, Israel

Taro board rejects Sun Pharma offer for total control

Taro board rejects Sun Pharma offer for total control

Hindu BusinessLine, India

Taro Pharmaceutical announces rejection of Sun Pharma's proposal

Taro Pharmaceutical announces rejection of Sun Pharma's proposal

The Fly on the Wall

Sun Pharma Profit Beats Estimates on Israeli Unit’s Sales Gain

Sun Pharma Profit Beats Estimates on Israeli Unit’s Sales Gain

Bloomberg

News

Sun Pharma unimpressed with Taro results

Globes, Israel

News

Taro Pharmaceutical net zooms by 93% in Q3

PharmaBiz